§ Federal grant opportunity · RFA-DA-27-012
NIH Blueprint Initiative: Tools for Germline Gene Editing in the Nervous System
National Institutes of Health is accepting applications for NIH Blueprint Initiative: Tools for Germline Gene Editing in the Nervous System. The deadline is Rolling / not published and the published award range is $1.2M.
Key facts
- Funder
- National Institutes of Health
- Application deadline
- Rolling / not published
- Award range
- $1.2M
- Eligibility
- other, small businesses, city or township governments, private institutions of higher education, federally recognized native american tribal governments, county governments, nonprofits non higher education with 501c3, public and indian housing authorities, other native american tribal organizations, independent school districts, nonprofits non higher education without 501c3, public and state institutions of higher education, state governments, for profit organizations other than small businesses, special district governments
- Geography
- United States
- Focus areas
- Health
- Opportunity number
- RFA-DA-27-012
Program overview
The NIH Blueprint (a consortium of NIH Institutes that support neuroscience research) seeks to advance its mission by supporting the development, optimization, validation, and application of germline and somatic transgenic and gene-editing approaches in experimental systems modeling key features of human brain anatomy, circuitry, cognition, behavior, and lifespan. This initiative will build on the previously supported marmoset gene-editing infrastructure, by integrating New Approach Methodologies (NAMs) with other models, to advance understanding of human brain function and disease, including human-derived NAMs for cross-species comparisons across development. Many mechanisms of complex conditions, such as autism spectrum disorders, schizophrenia, and other behavioral/developmental disorders, cannot yet be captured in NAMs and are therefore high priorities for research investment to accelerate development and validation of human-derived NAMs. Appropriate models should be used and clearly justified as necessary for questions involving neuroanatomy, circuit function, cognition, behavior, or lifespan phenotyping related to human brain disease and function. Grant authorities are as follows: 42 U.S.C 241 and 284.
How to apply
- Confirm your organization meets the eligibility criteria above.
- Read the full funding opportunity announcement from National Institutes of Health.
- Draft your narrative against the funder's stated priorities and review criteria.
- Submit before Rolling / not published, allowing time for registration and validation.
Related grant opportunities
- Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Administrative Resource (U24 Clinical Trials Optional)
- Notice of Intent to Publish a Funding Opportunity Announcement for Single Source for Continuation of the Environmental Determinants of Diabetes in The Young Study (TEDDY) Data Coordinating Center (U01 Clinical Trial Not Allowed)
- Notice of Funding Opportunity for the Delta Health Care Services Grant (DHCS) for Fiscal Year 2026
- Computational and Data-Enabled Science and Engineering (CDS&E)
- Fiscal Year (FY) 2027 Service Area Competition (SAC)
Find every grant your organization qualifies for
Mavenly scores this opportunity against your mission, geography, and funding history — then drafts the proposal with you and tracks the deadline through submission and reporting.